Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2025-12-25 @ 8:05 PM
Study NCT ID:
NCT01726335
Status:
COMPLETED
Last Update Posted:
2014-04-29
First Post:
2012-11-09
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia
Sponsor:
Janssen-Cilag Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR012484
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None